HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 22.204 ↑ 0.2%
[as on 17 August, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 17 August, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 25.78% 0.2% -0.07% 3.23% 11.87% 25.3%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -3.58% -0.04% -0.76% 2.34% 3.31% -2.32% 8.38% 14.27% 16.96% 14.25%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -1.47% 0.12% -0.77% 0.83% 6.6% 4.14% 11.23% 9.9% 13.9% 12.2%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 23.56% -0.65% -0.95% 3.05% 12.35% 20.77% 24.34% 18.76% 26.42% 15.07%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.94% -0.26% -0.14% -0.11% 1.93% 8.04% 16.43% 18.29% 20.37% 15.67%
SBI PSU Fund - DIRECT PLAN - GROWTH 2.2% -0.21% 0.25% 0.48% -1.3% 11.88% 24.31% 24.93% 21.45% 14.7%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthOct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026
Returns 2.16% 1.22% -1.38% -4.65% 6.99% -4.36% 7.84% 5.11% 6.59% 3.59%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 18.05%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
17 August, 202622.204 0.2%
14 August, 202622.159 -0.03%
13 August, 202622.166 -0.06%
12 August, 202622.179 -0.87%
11 August, 202622.373 0.69%
10 August, 202622.22 0.14%
7 August, 202622.19 0.48%
6 August, 202622.085 0.18%
5 August, 202622.046 0.52%
4 August, 202621.933 -0.27%
3 August, 202621.992 0.93%
31 July, 202621.79 0.08%
30 July, 202621.772 -0.3%
29 July, 202621.838 1.37%
28 July, 202621.543 -0.11%
27 July, 202621.566 1.47%
24 July, 202621.253 -0.22%
23 July, 202621.3 -0.68%
22 July, 202621.446 -1.42%
21 July, 202621.755 0.17%
20 July, 202621.718 0.97%
17 July, 202621.51 -0.87%
16 July, 202621.699 0.14%
15 July, 202621.669 0.83%
14 July, 202621.49 0.6%
13 July, 202621.361 0.03%
10 July, 202621.354 0.19%
9 July, 202621.313 1.52%
8 July, 202620.994 -1.07%
7 July, 202621.221

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 22.204 as on 17 August, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 25.78% as on 17 August, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 25.3% as on 17 August, 2026.